PathXL close significant investment round led by E-Synergy

Press Release
PathXL close significant investment round led by E-Synergy
_____________________________________________________________________

Belfast, Northern Ireland - January 2012

As part of PathXL’s expansion, the company is delighted to announce a significant investment round to underpin the next steps of its strategy. As part of this, Tristan Brittain-Dissont, Fund Manager for E-Synergy’s Northern Ireland Spin-Out Funds, has joined the company’s board.

Tristan commented;

“E-Synergy is delighted to be playing a key role in supporting PathXL’s new business strategy. By diversifying into new markets in new geographies and by looking at both innovative service and product offerings, the company is creating a strong platform for growth and success”.

Des Speed, CEO PathXL commented,

“Alongside the investment funds from QUBIS and Crescent Capital, our largest shareholder, this enables the company to continue its expansion into North America, Europe and beyond; and to further strengthen the product focus in Stratified Medicine as well as support to Clinical Workflows, and our leading position in Education ”.

About PathXL

PathXL specialises in web-based software and workflows for Digital Pathology. Its PathXL™ Manager product provides a robust, secure and open web-based platform to enable digital pathology users across all fields to manage, view and collaborate around virtual slides easily and efficiently. In addition, PathXL provides a range of applications and workflows on top of PathXL™ Manager to deliver specific solutions to pathologists, scientists and students in Education, Research, Clinical and Biobanking settings. PathXL also provides a full range of supporting services, including scanning, hosting, image analysis and consultancy. PathXL operates in the UK, Europe and North America.

PathXL is a privately owned company, headquartered in Belfast, Northern Ireland. For more information please visit: http://www.pathxl.com